7 posts categorized by Mayes College of Healthcare and Business Policy

Federal Solutions to the Opioid Epidemic

Published on October 18, 2017

The Opioid Epidemic is a public health crisis, and there is no silver bullet. Read More

Categories: Opioids, Public Health, Mayes College of Healthcare and Business Policy, Department of Pharmaceutical and Healthcare Business, Department of Health Policy and Public Health, Substance Use Disorders Institute, Health Policy

0 Comments

 

Brief American History of Opioids in Medicine

Published on October 18, 2017

Even with an increased awareness and regulations, there is still much to do to solve the opioid crisis. Read More

Categories: Substance Use Disorders Institute, Mayes College of Healthcare and Business Policy, Pharmaceutical and Healthcare Business, Health Policy, Department of Health Policy and Public Health, Public Health, Opioids

0 Comments

 

Professor Richard Minoff Presents at Academy of Business Research Conference

Published on October 12, 2017

Professor Richard Minoff, director of the pharmaceutical and healthcare business program, delivered a presentation at the Academy of Business Research Conference in Atlantic City on September 18th.  Read More

Categories: Mayes College of Healthcare and Business Policy, Pharmaceutical and Healthcare Business, Department of Pharmaceutical and Healthcare Business, Faculty, Presentation

0 Comments

 

The Pharmacist's Role in Medical Marijuana

Published on October 11, 2017

Pharmacists’ clinical expertise in medications makes them uniquely qualified to manage and dispense medical cannabis, enabling patients to have better care. Read More

Categories: Marijuana, Department of Health Policy and Public Health, Public Health, Department of Pharmaceutical and Healthcare Business, Mayes College of Healthcare and Business Policy, Students, Substance Use Disorders Institute, Health Policy

0 Comments

 

Medical Marijuana and its Analgesic Potential in Pain

Published on October 11, 2017

Marijuana’s therapeutic use is not limited to cancer or neuropathic pain. Current findings are limited because of its federal restrictions, yet it is continuously being researched as an option for many indications such as multiple sclerosis, post-traumatic stress disorder, and seizures. Read More

Categories: Health Policy, Substance Use Disorders Institute, Department of Health Policy and Public Health, Students, Public Health, Marijuana, Department of Pharmaceutical and Healthcare Business, Mayes College of Healthcare and Business Policy

0 Comments

 

Substance Use Disorders Institute: Cannabidiol Should Not be Subject to Control as a Scheduled Substance

Published on September 26, 2017

The newly formed Substance Use Disorders Institute (SUDI) at USciences submitted a recommendation to the U.S. Food and Drug Administration in September regarding Cannabidiol. Read More

Categories: Substance Use Disorders Institute, Department of Health Policy and Public Health, USciences, Mayes College of Healthcare and Business Policy

0 Comments

 

USciences Involved in the Healthier You Conference

Published on October 8, 2016

USciences’ Community and Government Affairs, Philadelphia College of Pharmacy, Mayes College of Healthcare Business and Policy, and the Exercise and Wellness Management Program were all involved in The Healthier You Conference 2016 held in South Philadelphia on October 8, 2016. The event attracted... Read More

Categories: Philadelphia College of Pharmacy, Community and Government Affairs, Exercise Science and Wellness Management, Mayes College of Healthcare and Business Policy, Event

0 Comments